Logo image of SBNOR.OL

SPAREBANKEN NORGE (SBNOR.OL) Stock Fundamental Analysis

OSL:SBNOR - NO0006000900 - Common Stock

169.12 NOK
-0.54 (-0.32%)
Last: 9/11/2025, 9:19:02 AM
Fundamental Rating

3

Overall SBNOR gets a fundamental rating of 3 out of 10. We evaluated SBNOR against 89 industry peers in the Banks industry. Both the profitability and financial health of SBNOR have multiple concerns. SBNOR is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year SBNOR was profitable.
In the past year SBNOR had a positive cash flow from operations.
SBNOR had positive earnings in each of the past 5 years.
In the past 5 years SBNOR always reported a positive cash flow from operatings.
SBNOR.OL Yearly Net Income VS EBIT VS OCF VS FCFSBNOR.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

1.2 Ratios

SBNOR has a Return On Assets (0.56%) which is in line with its industry peers.
SBNOR has a worse Return On Equity (7.67%) than 60.67% of its industry peers.
Industry RankSector Rank
ROA 0.56%
ROE 7.67%
ROIC N/A
ROA(3y)0.49%
ROA(5y)0.45%
ROE(3y)6.19%
ROE(5y)5.61%
ROIC(3y)N/A
ROIC(5y)N/A
SBNOR.OL Yearly ROA, ROE, ROICSBNOR.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6

1.3 Margins

SBNOR's Profit Margin of 23.18% is in line compared to the rest of the industry. SBNOR outperforms 57.30% of its industry peers.
SBNOR's Profit Margin has improved in the last couple of years.
The Operating Margin and Gross Margin are not available for SBNOR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 23.18%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y12.59%
PM growth 5Y16.7%
GM growth 3YN/A
GM growth 5YN/A
SBNOR.OL Yearly Profit, Operating, Gross MarginsSBNOR.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1

2. Health

2.1 Basic Checks

SBNOR does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, SBNOR has about the same amount of shares outstanding.
The number of shares outstanding for SBNOR has been increased compared to 5 years ago.
SBNOR has a worse debt/assets ratio than last year.
SBNOR.OL Yearly Shares OutstandingSBNOR.OL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
SBNOR.OL Yearly Total Debt VS Total AssetsSBNOR.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100B 200B 300B

2.2 Solvency

SBNOR has a debt to FCF ratio of 41.53. This is a negative value and a sign of low solvency as SBNOR would need 41.53 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 41.53, SBNOR is doing good in the industry, outperforming 69.66% of the companies in the same industry.
A Debt/Equity ratio of 7.02 is on the high side and indicates that SBNOR has dependencies on debt financing.
SBNOR has a worse Debt to Equity ratio (7.02) than 89.89% of its industry peers.
Industry RankSector Rank
Debt/Equity 7.02
Debt/FCF 41.53
Altman-Z N/A
ROIC/WACCN/A
WACC5.73%
SBNOR.OL Yearly LT Debt VS Equity VS FCFSBNOR.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
SBNOR.OL Yearly Current Assets VS Current LiabilitesSBNOR.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 15.35% over the past year.
Measured over the past years, SBNOR shows a quite strong growth in Earnings Per Share. The EPS has been growing by 17.42% on average per year.
Looking at the last year, SBNOR shows a very strong growth in Revenue. The Revenue has grown by 25.49%.
The Revenue has been growing by 10.96% on average over the past years. This is quite good.
EPS 1Y (TTM)15.35%
EPS 3Y22.09%
EPS 5Y17.42%
EPS Q2Q%10.18%
Revenue 1Y (TTM)25.49%
Revenue growth 3Y9.69%
Revenue growth 5Y10.96%
Sales Q2Q%59.71%

3.2 Future

SBNOR is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -1.45% yearly.
SBNOR is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 19.99% yearly.
EPS Next Y-8.83%
EPS Next 2Y-5.24%
EPS Next 3Y-1.45%
EPS Next 5YN/A
Revenue Next Year52.61%
Revenue Next 2Y29.62%
Revenue Next 3Y19.99%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
SBNOR.OL Yearly Revenue VS EstimatesSBNOR.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B 8B 10B
SBNOR.OL Yearly EPS VS EstimatesSBNOR.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 5 10 15

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 9.70, the valuation of SBNOR can be described as reasonable.
The rest of the industry has a similar Price/Earnings ratio as SBNOR.
When comparing the Price/Earnings ratio of SBNOR to the average of the S&P500 Index (27.03), we can say SBNOR is valued rather cheaply.
The Price/Forward Earnings ratio is 11.31, which indicates a very decent valuation of SBNOR.
Based on the Price/Forward Earnings ratio, SBNOR is valued a bit more expensive than the industry average as 61.80% of the companies are valued more cheaply.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.54, SBNOR is valued a bit cheaper.
Industry RankSector Rank
PE 9.7
Fwd PE 11.31
SBNOR.OL Price Earnings VS Forward Price EarningsSBNOR.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, SBNOR is valued a bit cheaper than the industry average as 78.65% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 6.72
EV/EBITDA N/A
SBNOR.OL Per share dataSBNOR.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)0.56
EPS Next 2Y-5.24%
EPS Next 3Y-1.45%

5

5. Dividend

5.1 Amount

SBNOR has a Yearly Dividend Yield of 5.13%, which is a nice return.
SBNOR's Dividend Yield is comparable with the industry average which is at 5.09.
SBNOR's Dividend Yield is rather good when compared to the S&P500 average which is at 2.45.
Industry RankSector Rank
Dividend Yield 5.13%

5.2 History

The dividend of SBNOR is nicely growing with an annual growth rate of 42.04%!
Dividend Growth(5Y)42.04%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

SBNOR pays out 112.92% of its income as dividend. This is not a sustainable payout ratio.
The Dividend Rate of SBNOR has been growing, while earnings will be declining. This means the dividend growth is most likely not sustainable.
DP112.92%
EPS Next 2Y-5.24%
EPS Next 3Y-1.45%
SBNOR.OL Yearly Income VS Free CF VS DividendSBNOR.OL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B
SBNOR.OL Dividend Payout.SBNOR.OL Dividend Payout, showing the Payout Ratio.SBNOR.OL Dividend Payout.PayoutRetained Earnings

SPAREBANKEN NORGE

OSL:SBNOR (9/11/2025, 9:19:02 AM)

169.12

-0.54 (-0.32%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)08-12 2025-08-12/dmh
Earnings (Next)11-06 2025-11-06
Inst Owners20.23%
Inst Owner ChangeN/A
Ins Owners0.51%
Ins Owner ChangeN/A
Market Cap28.69B
Analysts80
Price Target164.48 (-2.74%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 5.13%
Yearly Dividend24.37
Dividend Growth(5Y)42.04%
DP112.92%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.88%
Min EPS beat(2)-3.55%
Max EPS beat(2)5.31%
EPS beat(4)3
Avg EPS beat(4)5.86%
Min EPS beat(4)-3.55%
Max EPS beat(4)14.66%
EPS beat(8)6
Avg EPS beat(8)4.43%
EPS beat(12)8
Avg EPS beat(12)12.21%
EPS beat(16)12
Avg EPS beat(16)13.75%
Revenue beat(2)0
Avg Revenue beat(2)-7.09%
Min Revenue beat(2)-13.13%
Max Revenue beat(2)-1.06%
Revenue beat(4)2
Avg Revenue beat(4)0.5%
Min Revenue beat(4)-13.13%
Max Revenue beat(4)8.42%
Revenue beat(8)6
Avg Revenue beat(8)16.3%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)3.76%
PT rev (3m)N/A
EPS NQ rev (1m)2.76%
EPS NQ rev (3m)-0.14%
EPS NY rev (1m)1.35%
EPS NY rev (3m)1.35%
Revenue NQ rev (1m)9.91%
Revenue NQ rev (3m)19.43%
Revenue NY rev (1m)4.27%
Revenue NY rev (3m)5.95%
Valuation
Industry RankSector Rank
PE 9.7
Fwd PE 11.31
P/S 3.43
P/FCF 6.72
P/OCF 6.62
P/B 1.14
P/tB 1.16
EV/EBITDA N/A
EPS(TTM)17.43
EY10.31%
EPS(NY)14.95
Fwd EY8.84%
FCF(TTM)25.16
FCFY14.88%
OCF(TTM)25.55
OCFY15.1%
SpS49.26
BVpS148.81
TBVpS145.55
PEG (NY)N/A
PEG (5Y)0.56
Profitability
Industry RankSector Rank
ROA 0.56%
ROE 7.67%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 23.18%
GM N/A
FCFM 51.08%
ROA(3y)0.49%
ROA(5y)0.45%
ROE(3y)6.19%
ROE(5y)5.61%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y12.59%
PM growth 5Y16.7%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity 7.02
Debt/FCF 41.53
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 0.78%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 220.36%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score5
WACC5.73%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)1.41%
Cap/Sales(5y)1.57%
Profit Quality(3y)228.55%
Profit Quality(5y)217.4%
High Growth Momentum
Growth
EPS 1Y (TTM)15.35%
EPS 3Y22.09%
EPS 5Y17.42%
EPS Q2Q%10.18%
EPS Next Y-8.83%
EPS Next 2Y-5.24%
EPS Next 3Y-1.45%
EPS Next 5YN/A
Revenue 1Y (TTM)25.49%
Revenue growth 3Y9.69%
Revenue growth 5Y10.96%
Sales Q2Q%59.71%
Revenue Next Year52.61%
Revenue Next 2Y29.62%
Revenue Next 3Y19.99%
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y56.85%
FCF growth 3Y28.27%
FCF growth 5Y61.38%
OCF growth 1Y52.46%
OCF growth 3Y27.09%
OCF growth 5Y18.41%